Financial Ratios | Torrent Pharmaceuticals Ltd. | R Wadiwala Securities Pvt Ltd

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent
BSE3339.05-15.4 (-0.46 %)
PREV CLOSE (Rs.) 3354.45
OPEN PRICE (Rs.) 3345.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9329
TODAY'S LOW / HIGH (Rs.)3315.05 3345.40
52 WK LOW / HIGH (Rs.)2891.45 3589.95
NSE3339.40-14.3 (-0.43 %)
PREV CLOSE( Rs. ) 3353.70
OPEN PRICE (Rs.) 3350.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3339.40 (4)
VOLUME 435962
TODAY'S LOW / HIGH(Rs.) 3311.30 3350.00
52 WK LOW / HIGH (Rs.)2870 3590.7

Financial Ratios

Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)56.4748.9436.7945.9273.97
   CEPS(Rs)79.9672.8257.6742.5256.42
   DPS(Rs)32.0028.0022.0048.0035.00
   Book NAV/Share(Rs)224.27202.57183.13351.75344.90
   Tax Rate(%)28.4929.5832.5936.6017.98
Margin Ratios
   Core EBITDA Margin(%)21.9820.1317.3015.9816.67
   EBIT Margin(%)17.3616.2013.369.7412.63
   Pre Tax Margin(%)15.8614.0811.328.0610.26
   PAT Margin (%)11.349.927.635.118.41
   Cash Profit Margin (%)16.0614.7511.969.4612.84
Performance Ratios
   ROA(%)13.2311.439.205.929.20
   ROE(%)26.4625.3820.5013.1823.49
   ROCE(%)27.3224.2820.3214.3517.62
   Asset Turnover(x)1.171.151.211.161.09
   Sales/Fixed Asset(x)1.221.271.391.431.43
   Working Capital/Sales(x)18.6289.70-122.1820.2823.62
Efficiency Ratios
   Fixed Capital/Sales(x)0.820.790.720.700.70
   Receivable days40.1841.3839.9937.8638.92
   Inventory Days52.2049.2652.4761.7159.24
   Payable days279.17279.66243.50306.08383.19
Valuation Parameters
   PER(x)57.2853.1541.7930.4517.18
   PCE(x)40.4535.7226.6632.8822.52
   Price/Book(x)14.4212.848.407.957.37
   Yield(%)0.991.081.431.721.38
   EV/Net Sales(x)9.728.505.905.995.90
   EV/Core EBITDA(x)29.8926.6019.6619.3818.62
   EV/EBIT(x)38.2633.6826.0334.4025.13
   EV/CE(x)10.548.444.944.043.46
   M Cap / Sales9.518.215.415.565.37
Growth Ratio
   Net Sales Growth(%)7.3511.5113.076.290.82
   Core EBITDA Growth(%)9.3018.659.873.5810.71
   EBIT Growth(%)8.1124.0847.24-21.1914.78
   PAT Growth(%)15.3933.0260.22-37.9222.17
   EPS Growth(%)15.3933.02-19.88-37.9222.17
Financial Stability Ratios
   Total Debt/Equity(x)0.400.570.850.680.83
   Current Ratio(x)1.191.030.981.171.13
   Quick Ratio(x)0.660.620.570.620.59
   Interest Cover(x)11.597.656.545.815.32
   Total Debt/Mcap(x)0.030.040.100.080.11